Medarva Innovations
Medarva Innovations is a healthcare services provider that caters to a diverse range of patients. The organization focuses on delivering quality care and innovative solutions to meet the varied needs of its clientele. By emphasizing patient-centered approaches, Medarva Innovations aims to enhance health outcomes and improve the overall healthcare experience.
Top Regions
Top Stages
1 past transactions
TearSolutions
Series A in 2015
TearSolutions, Inc. is a biotechnology company based in Charlottesville, Virginia, founded in 2013. The company focuses on developing innovative therapies for dry eye conditions, particularly through its proprietary product, Lacripep. This synthetic peptide treatment is designed to mimic the natural tear protein lacritin, aiming to restore basal tearing and improve corneal health without causing irritation. TearSolutions is currently advancing Lacripep through phase II human clinical trials, targeting patients with primary Sjögren's syndrome. The company's approach preserves the biological activity of natural tear proteins while providing a scalable solution to address the symptoms of dry eyes effectively.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.